CYTOSORBENTS CORPORATI

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

04 6 2024 06:00:00 提供 Nasdaq GlobeNewswire

CytoSorbents Reports First Quarter 2024 Results

09 5 2024 15:17:23 提供 Nasdaq GlobeNewswire

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

02 5 2024 06:00:00 提供 Nasdaq GlobeNewswire

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

26 4 2024 06:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

17 4 2024 08:45:06 提供 NetDania Notify

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

17 4 2024 06:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

16 4 2024 08:57:39 提供 NetDania Notify

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

14 3 2024 15:39:31 提供 Nasdaq GlobeNewswire

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

06 3 2024 06:00:00 提供 Nasdaq GlobeNewswire

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

08 2 2024 06:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

25 1 2024 09:26:32 提供 NetDania Notify

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

17 1 2024 06:15:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

08 1 2024 09:16:09 提供 NetDania Notify

NetDania - New 12 months Low: CYTOSORBENTS CORPORATION - COMMON STOCK

28 12 2023 08:48:08 提供 NetDania Notify

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

28 12 2023 06:00:00 提供 Nasdaq GlobeNewswire

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

13 12 2023 08:15:00 提供 Nasdaq GlobeNewswire

CytoSorbents Reports Third Quarter 2023 Financial and Operational Results

09 11 2023 15:15:00 提供 Nasdaq GlobeNewswire

CytoSorbents to Report Third Quarter 2023 Operating and Financial Results

27 10 2023 06:00:00 提供 Nasdaq GlobeNewswire

CytoSorbents to Present at the 8th Annual Dawson James Conference

05 10 2023 06:00:00 提供 Nasdaq GlobeNewswire

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

27 9 2023 06:00:00 提供 Nasdaq GlobeNewswire